Mid Diagnosed 2026-10-21 21:07:15 KST
M
MEDP AI Stock Diagnostic Report
Medpace beats Q3 estimates but guides below on revenue Medface's third-quarter earnings exceeded expectations, but its revenue guidance fell below market expectations, suggesting a mixed outlook for the stock price.
View Source Article ↗ AI CATALYST SCORE 55 / 100 Score computed by Sentinel V12
REFERENCE PRICE Not measured Reference entry price at analysis time
AI REFERENCE SCORE A reference score computed by the analysis engine from news and filings.
Report Info
Tier Mid
Diagnosed At 2026-10-21 21:07:15
Content Review Reviewed
Company Facts
Next Ex-Dividend Date No Dividend
Next Earnings Date Collecting
Latest SEC Filing 2026-10-23T16:11:03-04:00 Data Composition Shows Sentinel V12's AI analysis, plus (for S-Class) Python Engine technical indicators and stored OHLC data.
+ ANALYSIS HISTORY
MEDP Analysis History (Last 30 Days)